Sectoral Asset Management
Investor profile
Deals
3
distinct rounds
Companies
3
backed
Active span
2009–2023
15 yrs
Total round €
€211M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Advent Venture Partners1
- Aisling Capital1
- Andera Partners1
- ATEM1
- Brace Pharma1
- Crédit Agricole Création1
- CTI Life Sciences1
- EQT Life Sciences1
- Innobio 21
- Intermediate Capital Group1
- Kurma Partners1
- Mass General Brigham Ventures1
- Merifin Capital1
- Morningside Ventures1
- Novartis Venture Fund1
- Novo A1
- Novo Holdings1
- OrbiMed1
- Pontifax Funds1
- Relyens Innovation Santé/Turenne Capital1
- S1
- Sofinnova Partners1
- Sunstone Capital1
- Tekla Capital Management1
- Ventech1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Amolyt Pharma | France | 1 | €129M |
| F2G | UK | 1 | €55M |
| BioVex | UK | 1 | €27M |